Healthcare supply across the AmericasCapability briefings for qualified organizationsExisting client access →

POLICY 04 · SHIPPING

Shipping, Delivery & Risk-of-Loss Policy

How estimates, shipment terms, risk transfer, receiving readiness, temperature-sensitive handling, cross-border obligations, delays, and carrier claims are managed.

01

1. Written order controls

Shipping method, trade term, origin, destination, carrier, packaging, monitoring, insurance, delivery window, and special handling are determined by the accepted order and lane plan. Portal displays and preliminary estimates are not a shipping commitment.

02

2. Dates are estimates; time is not of the essence

Unless an authorized written agreement expressly states a guaranteed date and remedy, production, release, ship, transit, customs, and delivery dates are good-faith estimates only; time is not of the essence; and delay does not by itself create cancellation, refund, cover, or consequential-damage rights. Client should not make downstream commitments that assume an unconfirmed date.

03

3. Default shipment term and title

Unless the accepted order expressly states another term, domestic shipments are shipment contracts, freight prepaid and added or freight collect as determined by Pharma Americas, and risk of loss passes to Client when the goods are tendered to the first carrier at origin. Title passes only upon full payment, but retention of title does not shift risk of loss back to Pharma Americas. For international transactions, the accepted order should identify the applicable Incoterms® 2020 rule and named place.

04

4. Client shipping and receiving responsibilities

  • Provide a complete, accurate, lawful, and serviceable delivery address, contact, receiving hours, dock or access instructions, permits, and advance-notice requirements before the cutoff.
  • Ensure qualified personnel, space, equipment, monitoring capability, and required storage conditions are ready at the delivery window.
  • Receive promptly; inspect external condition, seal, quantity, identity, monitors, and documents; and record exceptions before further handling where practicable.
  • Prevent delivery to an unattended, residential, personal, unauthorized, sanctioned, restricted, or unqualified destination.
  • Pay redelivery, address-correction, storage, demurrage, detention, abandonment, return, disposal, and similar charges caused by Client, consignee, destination, or inaccurate instructions.
05

5. Temperature-sensitive and controlled-condition shipments

Packaging and lane planning are based on the accepted requirements, planned route, season, carrier service, and information available before dispatch. Thermal packaging is a shipment control and is not permanent storage. A monitor reading, delay, or packaging condition does not by itself determine product disposition; authorized reviewers must evaluate the relevant specification, method, duration, evidence, and applicable agreement.

Client must prioritize receipt, move goods to the required environment without avoidable delay, preserve packaging and monitor data, and follow the complaint policy for any concern. Failure of receiving readiness, missed delivery, address error, or delay after risk transfer may affect remedy eligibility.

06

6. Cross-border and trade compliance

Unless the accepted order assigns a specific responsibility to Pharma Americas, Client is the importer of record and is responsible for product admissibility, intended use, permits, registrations, licenses, classifications, declarations, taxes, duties, brokerage, end-use and end-user information, local delivery, and destination compliance. Pharma Americas is not a customs broker, regulator, legal advisor, or guarantor of clearance.

Pharma Americas may screen parties, destinations, end uses, and transactions; request documents; hold or cancel performance; refuse routing; or report information where required or appropriate under sanctions, export-control, anti-diversion, customs, or other law.

07

7. Partial shipments, routing, and allocation

Pharma Americas may make partial shipments, use commercially reasonable carriers or routes, consolidate or separate shipments, and allocate supply unless the accepted order expressly prohibits the action. Each partial shipment may be invoiced separately. A change that materially affects an accepted product specification or expressly agreed controlled condition requires the approval stated in the order.

08

8. Carrier events, loss, and claims

After risk of loss transfers, carrier delay, loss, theft, damage, misdelivery, customs hold, temperature event, or other transit event is Client’s risk except to the extent an accepted order or non-waivable law expressly provides otherwise. Pharma Americas may assist with a carrier or insurance claim as a commercial courtesy and may require an assignment, proof of loss, packaging, photos, delivery notation, records, and cooperation. Assistance is not an admission or guarantee of recovery.

Client must follow the Returns & Cancellations and Complaint Handling policies and all carrier claim deadlines. Client may not reject, abandon, or return a shipment without written direction unless required for immediate safety or by law.

09

9. Force majeure and regulatory holds

Pharma Americas is not liable for delays or inability to perform caused by events outside reasonable control, including supplier, carrier, port, border, customs, authority, labor, infrastructure, utility, cyber, weather, disaster, epidemic, war, terrorism, civil disorder, embargo, sanction, shortage, or export-control events. Pharma Americas may hold, reroute, allocate, use a lawful alternative, extend timing, or cancel an affected portion without consequential liability.

Official federal references

These primary sources inform the published operating baseline. They are not endorsements, licenses, or legal determinations about Pharma Americas or any client, product, supplier, destination, or transaction.

U.S. Department of the Treasury — OFACA Framework for OFAC Compliance Commitments

Risk-based sanctions diligence across customers, counterparties, supply chains, products, and geographies.

Open official source ↗
U.S. Department of Commerce — BISExport Compliance Programs

Federal guidance on export authorization procedures, screening, recordkeeping, risk assessment, and escalation.

Open official source ↗

A POLICY IS A BASELINE

Confirm the transaction-specific terms in writing.

Product, service, destination, evidence, timing, risk allocation, and professional responsibilities can change the required controls. An accepted order document or signed agreement should record the final scope.

Request a program reviewView all policies